▶ 調査レポート

ポリピル製品の世界市場2019-2027：用途別（心血管系、糖尿病、抗感染症、その他）、流通経路別
• 英文タイトル：Polypill Products Market (Application: Cardiovascular, Diabetes Mellitus, Anti-infective, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。ポリピル製品の世界市場2019-2027：用途別（心血管系、糖尿病、抗感染症、その他）、流通経路別 / Polypill Products Market (Application: Cardiovascular, Diabetes Mellitus, Anti-infective, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006022資料のイメージです。• レポートコード：TMR2006022
• 出版社/出版日：Transparency Market Research / 2020年3月
• レポート形態：英文、PDF、179ページ
• 納品方法：Eメール
• 産業分類：医薬品
• 販売価格（消費税別）
  Single User￥857,660 (USD5,795)▷ お問い合わせ
  Multi User￥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License￥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、ポリピル製品の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、用途別（心血管系、糖尿病、抗感染症、その他）分析、流通経路別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ）分析、競争状況などを総合的に調査・分析して掲載しております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・ポリピル製品の世界市場規模：用途別（心血管系、糖尿病、抗感染症、その他）
・ポリピル製品の世界市場規模：流通経路別
・ポリピル製品の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ）
・競争状況

Polypill Products Market – Scope of the Report

TMR’s report on the global polypill products market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global polypill products market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global polypill products market during the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global polypill products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global polypill products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global polypill products market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global polypill products market.

The report delves into the competition landscape of the global polypill products market. Key players operating in the global polypill products market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global polypill products market that have been profiled in this report.

Key Questions Answered in Polypill Products Market Report

What is the scope of growth for product companies in the global polypill products market?
What will be the Y-o-Y growth of the global polypill products market between 2019 and 2027?
What is the influence of changing trends in technologies on the global polypill products market?
Will North America continue to be the most profitable market for polypill products?
Which factors are anticipated to hamper the growth of the global polypill products market during the forecast period?
Which are the leading companies in the global polypill products market?
Research Methodology

A unique methodology has been utilized by TMR to conduct comprehensive research on the growth of the global polypill products market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global polypill products market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the polypill products market as primary methods.

These primary research respondents have provided exclusive information during interviews, which serves as a validation from the polypill products market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global polypill products market with accuracy. The study also uses the top-down approach to assess the revenues of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global polypill products more reliably and accurately.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Polypill Products Market

4. Market Overview

4.1. Introduction

4.1.1. Application/Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Polypill Products Market Analysis and Forecast, 2017–2027

5. Market Outlook

5.1. Epidemiology of Cardiovascular Diseases, Diabetes Mellitus and Infectious Diseases

5.2. Pipeline Analysis

5.3. Regulatory Scenario/Drug Approval Process, by Country/Sub-region

5.4. Technological Advancements

6. Global Polypill Products Market Analysis and Forecast, by Application

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Polypill Products Market Value Forecast, by Application, 2017–2027

6.3.1. Cardiovascular

6.3.2. Diabetes Mellitus

6.3.3. Anti-infective

6.3.4. Others

6.4. Global Polypill Products Market Attractiveness Analysis, by Application

7. Global Polypill Products Market Analysis and Forecast, by Distribution Channel

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Online Pharmacies

7.4. Global Polypill Products Market Attractiveness Analysis, by Distribution Channel

8. Global Polypill Products Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Polypill Products Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Polypill Products Market Attractiveness Analysis, by Region

9. North America Polypill Products Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. North America Polypill Products Market Value Forecast, by Application, 2017–2027

9.2.1. Cardiovascular

9.2.2. Diabetes Mellitus

9.2.3. Anti-infective

9.2.4. Others

9.3. North America Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. North America Polypill Products Market Value Forecast, by Country, 2017–2027

9.4.1. U.S.

9.4.2. Canada

9.5. North America Polypill Products Market Attractiveness Analysis

9.5.1. By Application

9.5.2. By Distribution Channel

9.5.3. By Country

10. Europe Polypill Products Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Europe Polypill Products Market Value Forecast, by Application, 2017–2027

10.2.1. Cardiovascular

10.2.2. Diabetes Mellitus

10.2.3. Anti-infective

10.2.4. Others

10.3. Europe Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.4. Europe Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

10.4.1. Germany

10.4.2. U.K.

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Rest of Europe

10.5. Europe Polypill Products Market Attractiveness Analysis

10.5.1. By Application

10.5.2. By Distribution Channel

10.5.3. By Country/Sub-region

11. Asia Pacific Polypill Products Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Asia Pacific Polypill Products Market Value Forecast, by Application, 2017–2027

11.2.1. Cardiovascular

11.2.2. Diabetes Mellitus

11.2.3. Anti-infective

11.2.4. Others

11.3. Asia Pacific Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

11.3.1. Hospital Pharmacies

11.3.2. Retail Pharmacies

11.3.3. Online Pharmacies

11.4. Asia Pacific Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

11.4.1. China

11.4.2. Japan

11.4.3. India

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Polypill Products Market Attractiveness Analysis

11.5.1. By Application

11.5.2. By Distribution Channel

11.5.3. By Country/Sub-region

12. Latin America Polypill Products Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Latin America Polypill Products Market Value Forecast, by Application, 2017–2027

12.2.1. Cardiovascular

12.2.2. Diabetes Mellitus

12.2.3. Anti-infective

12.2.4. Others

12.3. Latin America Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

12.3.1. Hospital Pharmacies

12.3.2. Retail Pharmacies

12.3.3. Online Pharmacies

12.4. Latin America Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Polypill Products Market Attractiveness Analysis

12.5.1. By Application

12.5.2. By Distribution Channel

12.5.3. By Country/Sub-region

13. Middle East & Africa Polypill Products Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Middle East & Africa Polypill Products Market Value Forecast, by Application, 2017–2027

13.2.1. Cardiovascular

13.2.2. Diabetes Mellitus

13.2.3. Anti-infective

13.2.4. Others

13.3. Middle East & Africa Polypill Products Market Value Forecast, by Distribution Channel, 2017–2027

13.3.1. Hospital Pharmacies

13.3.2. Retail Pharmacies

13.3.3. Online Pharmacies

13.4. Middle East & Africa Polypill Products Market Value Forecast, by Country/Sub-region, 2017–2027

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Polypill Products Market Attractiveness Analysis

13.5.1. By Application

13.5.2. By Distribution Channel

13.5.3. By Country/Sub-region

14. Competitive Landscape

14.1. Market Player – Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis/Ranking, by Company, 2018

14.3. Company Profiles

14.3.1. Pfizer Inc.

14.3.1.1. Company Overview

14.3.1.2. Company Financials

14.3.1.3. Growth Strategies

14.3.1.4. SWOT Analysis

14.3.2. AstraZeneca

14.3.2.1. Company Overview

14.3.2.2. Company Financials

14.3.2.3. Growth Strategies

14.3.2.4. SWOT Analysis

14.3.3. Merck & Co., Inc. (Merck Sharp & Dohme Corp)

14.3.3.1. Company Overview

14.3.3.2. Company Financials

14.3.3.3. Growth Strategies

14.3.3.4. SWOT Analysis

14.3.4. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)

14.3.4.1. Company Overview

14.3.4.2. Company Financials

14.3.4.3. Growth Strategies

14.3.4.4. SWOT Analysis

14.3.5. Dr. Reddy’s Laboratories Ltd.

14.3.5.1. Company Overview

14.3.5.2. Company Financials

14.3.5.3. Growth Strategies

14.3.5.4. SWOT Analysis

14.3.6. Cipla, Inc.

14.3.6.1. Company Overview

14.3.6.2. Company Financials

14.3.6.3. Growth Strategies

14.3.6.4. SWOT Analysis

14.3.7. Cadila Pharmaceuticals

14.3.7.1. Company Overview

14.3.7.2. Growth Strategies

14.3.7.3. SWOT Analysis

14.3.8. Grupo Ferrer International, S.A.

14.3.8.1. Company Overview

14.3.8.2. Growth Strategies

14.3.8.3. SWOT Analysis

14.3.9. Gebro Pharma GmbH

14.3.9.1. Company Overview

14.3.9.2. Growth Strategies

14.3.9.3. SWOT Analysis

14.3.10. Gilead Sciences, Inc.

14.3.10.1. Company Overview

14.3.10.2. Company Financials

14.3.10.3. Growth Strategies

14.3.10.4. SWOT Analysis

14.3.11. Takeda Pharmaceutical Company Limited

14.3.11.1. Company Overview

14.3.11.2. Company Financials

14.3.11.3. Growth Strategies

14.3.11.4. SWOT Analysis

List of Table

Table 01: Global Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 02: Global Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 03: Global Polypill Products Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 04: North America Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 05: North America Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 06: North America Polypill Products Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: Europe Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 08: Europe Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 09: Europe Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 11: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 12: Asia Pacific Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Latin America Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: Latin America Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Latin America Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 17: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Middle East & Africa Polypill Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
以下、関連資料のご紹介
  • 関節内補充療法の世界市場2019-2027：製品種類別（1回注射、3回注射、5回注射）、ソース別、用途別、流通経路別
    Viscosupplementation Market (Product Type: Single Injection, Three Injections, and Five Injections; Application: Knee Osteoarthritis, Hip Osteoarthritis, and Hand Osteoarthritis; Source: Animal and Non-animal; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027
    TMR2006020 2020年3月 201Pages
    本調査レポートでは、関節内補充療法の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、キーインサイト、製品種類別（1回注射、3回注射、5回注射）分析、薬物クラス別分析、用途別分析、ソース別分析、流通経路別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東アフ...
  • 呼吸器疾患治療の世界市場2019-2027：疾患別（喘息、慢性閉塞性肺疾患[COPD]、肺癌、呼吸器感染症、アレルギー性鼻炎、嚢胞性線維症[CF]、その他）、薬物クラス別、投与経路別、流通経路別
    Respiratory Disorders Treatment Market (Disease: Asthma, Chronic Obstructive Pulmonary Disease [COPD], Lung Cancer, Respiratory Tract Infection, Allergic Rhinitis, Cystic Fibrosis [CF], and Others; Drug Class: Bronchodilators, Corticosteroids, Combination Drugs, Antibiotics, Target Therapy, Immunotherapy, CFTR, and Others; Route of Administration: Oral, Nasal, and Injectable; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
    TMR2006019 2020年3月 182Pages
    本調査レポートでは、呼吸器疾患治療の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、疾患別（喘息、慢性閉塞性肺疾患[COPD]、肺癌、呼吸器感染症、アレルギー性鼻炎、嚢胞性線維症[CF]、その他）分析、薬物クラス別分析、投与経路別分析、流通経路別分析、地域別...
  • 医療大麻の世界市場2019-2027：誘導体別（カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他）、用途別、投与経路別、流通経路別
    Medical Cannabis Market (Derivative: Cannabidiol [CBD], Tetrahydrocannabinol [THC], and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
    TMR2006017 2020年3月 172Pages
    本調査レポートでは、医療大麻の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、誘導体別（カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他）分析、用途別分析、投与経路別分析、流通経路別分析、地域別（北米、ヨーロッパ、中南米、その他の地域...
  • IBD(潰瘍性大腸炎及びクローン病)治療の世界市場：薬物クラス別、病気徴候別、流通経路別
    IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market (Drug Class: TNF Inhibitors, Aminosalicylates, Integrin Antagonists, and Corticosteroids; Disease Indication: Ulcerative Colitis and Crohn’s Disease; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
    TPM-2JN114 2019年11月7日 195Pages
    本調査レポートはIBD(潰瘍性大腸炎及びクローン病)治療の世界市場について調査・分析し、序論、仮定・研究方法、エグゼクティブサマリー、市場動向、薬物クラス別分析、病気徴候別分析、流通経路別分析、地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、次の構成でお届けいたし...
  • 規制物質の世界市場：薬物別、用途別、流通経路別
    Controlled Substance Market (Drug: Opioids, Stimulants, Depressants, Cannabinoids; Application: ADHD, Pain Management, Depression, Sleep Disorder, Cough Suppression, Anxiety, Seizure, Others; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
    TPM-2JN107 2019年11月13日 206Pages
    本調査レポートは規制物質の世界市場について調査・分析し、序論、仮定・研究手法、エグゼクティブサマリー、市場状況、市場動向、薬物別分析、用途別分析、流通経路別分析、地域別（北米、欧州、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、次の構成でお届けいたします。
    ・序論